These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus. Rygiel AM, Milano F, Ten Kate FJ, Schaap A, Wang KK, Peppelenbosch MP, Bergman JJ, Krishnadath KK. Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552 [Abstract] [Full Text] [Related]
9. Progression of Barrett's esophagus to adenocarcinoma despite antireflux surgery. von Conrady D, Smith MJ, Khan MF, Tan S, Mortimer G, McAnena OJ. Endoscopy; 2008 Sep; 40 Suppl 2():E68-9. PubMed ID: 18633915 [No Abstract] [Full Text] [Related]
10. Diagnosis and recognition of early esophageal neoplasia. Herszényi L, Pregun I, Tulassay Z. Dig Dis; 2009 Sep; 27(1):24-30. PubMed ID: 19439957 [Abstract] [Full Text] [Related]
11. Cancer risk in Barrett's oesophagus. Dias Pereira A, Suspiro A, Chaves P. Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):915-8. PubMed ID: 18049157 [Abstract] [Full Text] [Related]
19. Is there an advantage to be gained from adding digital image cytometry of brush cytology to a standard biopsy protocol in patients with Barrett's esophagus? Borovicka J, Schönegg R, Hell M, Kradolfer D, Bauerfeind P, Dorta G, Netzer P, Binek J, Meyenberger C, Fischer JE, Spieler P. Endoscopy; 2009 May; 41(5):409-14. PubMed ID: 19418394 [Abstract] [Full Text] [Related]
20. Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus. Srivastava A, Hornick JL, Li X, Blount PL, Sanchez CA, Cowan DS, Ayub K, Maley CC, Reid BJ, Odze RD. Am J Gastroenterol; 2007 Mar; 102(3):483-93; quiz 694. PubMed ID: 17338734 [Abstract] [Full Text] [Related] Page: [Next] [New Search]